Trial Outcomes & Findings for Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery (NCT NCT02819908)

NCT ID: NCT02819908

Last Updated: 2020-03-09

Results Overview

Based on Goldmann tonometry

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

25 participants

Primary outcome timeframe

To end of study (1 month postop)

Results posted on

2020-03-09

Participant Flow

Participant milestones

Participant milestones
Measure
Imprimis Dropless
TriMoxiVanc 0.2cc intravitreal one time Imprimis Dropless: Tri-Moxi-Vanc transzonular intravitreal injection
Imprimis Less Drops
Pred Moxi, 1 drop tid for 1 week then, PredKeterolac bid for 2-4 weeks. Imprimis Less Drops: Pred-Moxi-Ketorolac and Pred-Ketorolac topical instillation qd postoperatively
Overall Study
STARTED
12
13
Overall Study
COMPLETED
12
13
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

Based on Goldmann tonometry

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

Based on corneal pachymetry

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

"0"( on the eye pain/discomfort scale)

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

eye pain/discomfort scale

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

visual symptom scale

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

visual symptom scale

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

corneal pachymetry

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: To end of study (1 month postop)

Population: Study data has been lost to natural disaster (Hurricane Micheal), therefore there is no study data that is available to report

based on optical coherence tomography (OCT) measurement

Outcome measures

Outcome data not reported

Adverse Events

Imprimis Dropless

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Imprimis Less Drops

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Christina Menck

Eye Center of N Florida

Phone: 8507843937

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place